Eli Lilly, Qualcomm, Rumble: Market Minute

In This Article:

Yahoo Finance host Akiko Fujita highlights three of the top trending stocks and stories as part of today's Market Minute.

Pharmaceutical giant Eli Lilly's (LLY) GLP-1 weight-loss drug Zepbound received approval by the US Food and Drug Administration (FDA) to treat sleep apnea.

Qualcomm (QCOM) was found not to be in violation of an Arm (ARM) licensing agreement after the former's acquisition of Nuvia in 2021.

Rumble (RUM) shares skyrocket by over 80% Monday morning following a $775 million investment from crypto firm Tether (USDT-USD).

To watch more expert insights and analysis on the latest market action, check out more Wealth here.

This post was written by Luke Carberry Mogan.